Haoyue Zhang Selected Research

Anti-Bacterial Agents (Antibiotics)

1/2021

Discovery of Brominated Alboflavusins With Anti-MRSA Activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haoyue Zhang Research Topics

Disease

13	Glycogen Storage Disease Type II (Pompe's Disease) 06/2020 - 01/2005
8	Mucopolysaccharidoses 03/2024 - 07/2011
6	Insulin Resistance 01/2024 - 03/2009
6	Progeria (Hutchinson Gilford Syndrome) 01/2017 - 02/2013
4	Pain (Aches) 08/2022 - 01/2022
4	Malaria 01/2022 - 01/2019
3	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 12/2023 - 01/2013
3	Ischemic Stroke 11/2023 - 07/2021
3	Neuroinflammatory Diseases 08/2022 - 01/2022
3	Hyperalgesia 01/2022 - 01/2022
3	Inflammation (Inflammations) 01/2022 - 01/2019
3	Obesity 07/2019 - 11/2016
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2024 - 01/2022
2	Sepsis (Septicemia) 01/2023 - 09/2022
2	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2019
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 09/2022
2	Neoplasms (Cancer) 04/2022 - 01/2021
2	Chronic Pain 01/2022 - 01/2022
2	Postoperative Pain 01/2022 - 01/2022
2	Cancer Pain 01/2022 - 01/2022
2	Musculoskeletal Pain 01/2022 - 01/2022
2	Neuralgia (Stump Neuralgia) 01/2022 - 01/2022
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2022 - 01/2013
2	Fabry Disease (Fabry's Disease) 12/2020 - 01/2020
2	Mucopolysaccharidosis I (Hurler Syndrome) 09/2020 - 01/2020
2	Cholestasis 08/2020 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 07/2019 - 01/2012
2	Body Weight (Weight, Body) 01/2019 - 11/2016
2	Laminopathies 11/2016 - 02/2013
2	Premature Aging 04/2016 - 06/2014
1	Yin Deficiency (Yinxu) 04/2024
1	Reperfusion Injury 01/2024
1	Metabolic Diseases (Metabolic Disease) 01/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 11/2023
1	Burns 06/2023
1	Renal Insufficiency (Renal Failure) 01/2023
1	Liver Neoplasms (Liver Cancer) 01/2023
1	Stroke (Strokes) 11/2022
1	Bites and Stings (Sting) 08/2022
1	Neoplasm Metastasis (Metastasis) 04/2022
1	Colorectal Neoplasms (Colorectal Cancer) 04/2022
1	Hypersensitivity (Allergy) 01/2022
1	Bone Fractures (Bone Fracture) 01/2022
1	Tibial Fractures (Fracture, Tibial) 01/2022
1	Corneal Opacity 01/2022

Drug/Important Bio-Agent (IBA)

10	EnzymesIBA 12/2023 - 12/2006
9	AcidsIBA 06/2020 - 01/2005
9	GlycogenIBA 01/2019 - 01/2005
8	GlycosaminoglycansIBA 03/2024 - 07/2011
8	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2005
8	alpha-Glucosidases (Acid Maltase)IBA 01/2015 - 01/2005
4	Lamin Type A (Lamin A)IBA 01/2017 - 02/2013
3	ChemokinesIBA 08/2022 - 01/2022
3	Analgesics (Analgesic Drugs)IBA 08/2022 - 01/2022
3	Dermatan SulfateIBA 09/2020 - 01/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2009
3	Blood Glucose (Blood Sugar)IBA 07/2017 - 11/2016
3	glucose tetrasaccharideIBA 01/2015 - 07/2009
2	ChondroitinIBA 12/2023 - 01/2022
2	odiparcilIBA 12/2023 - 01/2022
2	CaspasesIBA 08/2022 - 01/2022
2	ArtesunateIBA 01/2022 - 01/2022
2	Glutamine (L-Glutamine)FDA Link 01/2021 - 01/2019
2	Heparitin Sulfate (Heparan Sulfate)IBA 09/2020 - 02/2015
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2017
2	Amino Acids FDA Link 01/2020 - 01/2019
2	ResveratrolIBA 07/2017 - 11/2016
2	Messenger RNA (mRNA)IBA 07/2017 - 11/2016
2	LaminsIBA 11/2016 - 02/2013
2	Histones (Histone)IBA 01/2016 - 02/2013
2	human GAA protein (Myozyme)FDA Link 02/2010 - 07/2009
1	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 04/2024
1	Dosage Forms (Dosage Form)IBA 04/2024
1	1,9-dimethylmethylene blueIBA 03/2024
1	Antitubercular AgentsIBA 01/2024
1	Sirtuin 1IBA 01/2024
1	xylosidesIBA 12/2023
1	Formaldehyde (Formol)FDA Link 06/2023
1	CausticsIBA 06/2023
1	CreatinineIBA 01/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 09/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2022
1	Caspase 6IBA 08/2022
1	InterferonsIBA 08/2022
1	cucurbitacin BIBA 04/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Aspartic Acid (Aspartate)FDA Link 01/2022
1	Transient Receptor Potential ChannelsIBA 01/2022
1	3,4-dihydroxyphenylglycolIBA 01/2022
1	artemisinin (artemisinine)IBA 01/2022

Therapy/Procedure

11	Therapeutics 12/2023 - 07/2009
7	Enzyme Replacement Therapy 09/2020 - 07/2009
2	Thrombectomy 11/2023 - 07/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Spinal Injections 01/2022